Now what do we do with all these genes? Yeast-based two-hybrid analysis: An emerging technology for molecular urology in the post-genome era

Urology

Volumn 53, Issue 4, 1999, Pages 835-842

  Gaston, Sandra M ^a   Loughlin, Kevin R ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CLINICAL RESEARCH; GENE FUNCTION; GENE ISOLATION; GENE SEQUENCE; GENETIC RISK; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; SEXUAL DEVELOPMENT; UROLOGY;

EID: 0033119152     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00604-9     Document Type: Review

References (16)

1. White M.A. The yeast two hybrid system forward and reverse . Proc Natl Acad Sci. 93:1996;10001-10003.
2. Vidal M., Brachmann R.K., Fattaey A., et al. Reverse two hybrid and one hybrid systems to detect dissociation of protein protein and DNA protein interactions. Proc Natl Acad Sci. 93:1996;10315-10320.
3. Vidal M., Braun P., Chen E., et al. Genetic characterization of a mammalian protein protein interactions domain by using a reverse two-hybrid system. Proc Natl Acad Sci. 93:1996;10321-10326.
4. Fields S., Song O. A novel genetic system to detect protein protein interactions. Nature. 340:1989;245-247.
5. Li B., Fields S. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. FASEB J. 7:1993;957-963.
6. Iwabuchi K., Bartel P.L., Li B., et al. Two cellular proteins that bind to wild type but not mutant p53. Proc Natl Acad Sci USA. 91:1994;6098-6102.
7. Haqq C.M., Donahoe P.K. Regulation of sexual dimorphism in mammals. Physiol Rev. 78:1998;1-33.
8. Poulat F., de Santa Barbara P., Desclozeaux M., et al. The human testis determining factor SRY binds a nuclear factor containing PDZ protein interaction domains. J Biol Chem. 272:1997;7167-7172.
9. Tajima T., Nakae J., Shinohara N., et al. A novel mutation localized in the 3′ non-HMG box region of the SRY gene in 46, XY gonadal dysgenesis. Hum Mol Genet. 3:1994;1187-1189.
10. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk a prospective study . Science. 279:1998;563-566.
11. Zhu J., Kahn C.R. Analysis of a peptide hormone-receptor interaction in the yeast two hybrid system. Proc Natl Acad Sci. 94:1997;13063-13068.
12. Yeh S., Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci. 93:1996;5517-5521.
13. Santoro M., Dathan N.A., Berlingieri M.T., et al. Molecular characterization of RET/PTC3 a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma . Oncogene. 9:1994;509-516.
14. Yeh S., Miyamoto H., Shima H., et al. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci. 95:1998;5527-5532.
15. Estojak J., Brent R., Golemis E.A. Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol. 15:1995;5820-5829.
16. Bartel P.L., Fields S. The Yeast Two Hybrid System. 1997;Oxford University Press, New York.